HomeELOX • OTCMKTS
add
Eloxx Pharmaceuticals Inc
Previous close
$0.00
Market cap
3.14 USD
Avg Volume
814.00
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Investing.com
9 hours ago
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.16%
0.21%
0.16%
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2023info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.64M | — |
Net income | -3.59M | — |
Net profit margin | — | — |
Earnings per share | -1.31 | 63.61% |
EBITDA | -3.62M | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.78M | — |
Total assets | 6.04M | — |
Total liabilities | 26.09M | — |
Total equity | -20.05M | — |
Shares outstanding | 3.14M | — |
Price to book | -0.00 | — |
Return on assets | -151.10% | — |
Return on capital | 1,421.81% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2023info | Y/Y change |
|---|---|---|
Net income | -3.59M | — |
Cash from operations | -3.45M | — |
Cash from investing | 233.00K | — |
Cash from financing | 3.67M | — |
Net change in cash | 453.00K | — |
Free cash flow | -149.00K | — |
About
Founded
1999
Headquarters
Website
Employees
18
